Laurus Labs Shares: SEBI RAs Divided On Outlook; Technicals Bullish, Fundamentals Worrying

Published : Jul 28, 2025, 02:10 PM IST
https://stocktwits.com/news-articles/markets/equity/laurus-labs-shares-sebi-r-as-divided-on-outlook-technicals-bullish-fundamentals-worrying/choeKf0R5DK

Synopsis

The stock is trading near its 52-week high, above key technical levels. But revenue and profit have sharply declined, keeping some analysts on guard.

Laurus Labs shares surged nearly 7% on Monday, hovering near its 52-week high. 

In recent news triggers, the government of Andhra Pradesh allotted 531.77 acres of land in IP Rambilli Phase-II, Anakapalli district. The pharma company plans to set up Laurus Pharma Zone (LPZ), a manufacturing center, in this space.

SEBI-registered analyst Sameer Pande noted that on a daily timeframe, the stock is indicating a strong upside movement, supported by strong volumes and Relative Strength Index (RSI)around 88. Other technical indicators such as MACD, VWAP and others also suggest a strong positive movement. 

On the monthly timeframe, Laurus Labs stock is showing a strong breakout pattern, trading above 100 and 200 day Exponential Moving Average (EMA), indicating a sustained uptrend. 

Pande identified strong support around ₹850-₹830 levels,

Last week, Laurus Labs reported their earnings performance for the June quarter. 

SEBI-registered Financial Independence rated it as a “ weak quarter” with sharp declines in both revenue and profit. They added that demand pressures from its Anti-Retroviral (ARV) division continue, though the Contract Development and Manufacturing Organization (CDMO) pipeline offers long-term potential.

Revenues fell 20% to ₹965 crore (YoY), impacted by weak ARV formulations and API business. While profits fell 80% to ₹33.4 crore, led by a lower operating leverage. Margins fell sharply to 15.8% vs 24.3% (YoY). 

Financial Independence remains cautious in the near-term on the stock.

Meanwhile, post the earnings report, Goldman Sachs maintains a ‘Sell’ rating with a target price of ₹675, indicating 20% downside. 

Data on Stocktwits shows that retail sentiment turned from ‘neutral’ to ‘bullish’ a day ago amid ‘high’ message volumes. 

Laurus Labs shares have risen 48% year-to-date (YTD).

For updates and corrections, email newsroom[at]stocktwits[dot]com.<

PREV

Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.

Read more Articles on

Recommended Stories

Mosaic Company Sells New Mexico Potash Mine To International Minerals In $30 Million Deal
Peter Schiff Calls Out Strategy’s $2B Cash Build Amid Inflation Risks — ‘Why Not Build Gold Reserves?’